% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{MelovanLent:162628,
      author       = {Melo van Lent, Debora and O'Donnell, Adrienne and Beiser,
                      Alexa S and Vasan, Ramachandran S and DeCarli, Charles S and
                      Scarmeas, Nikolaos and Wagner, Michael and Jacques, Paul F
                      and Seshadri, Sudha and Himali, Jayandra J and Pase, Matthew
                      P},
      title        = {{M}ind {D}iet {A}dherence and {C}ognitive {P}erformance in
                      the {F}ramingham {H}eart {S}tudy.},
      journal      = {Journal of Alzheimer's disease},
      volume       = {82},
      number       = {2},
      issn         = {1875-8908},
      address      = {Amsterdam},
      publisher    = {IOS Press},
      reportid     = {DZNE-2021-01324},
      pages        = {827 - 839},
      year         = {2021},
      abstract     = {Adherence to the Mediterranean-DASH for Neurodegenerative
                      Delay (MIND) diet has previously been associated with
                      cognitive decline and dementia. To our knowledge, no prior
                      study has investigated the association between the MIND diet
                      and measures of brain volume, silent brain infarcts (SBIs),
                      or brain atrophy.We evaluated whether adherence to the MIND
                      diet associated with superior cognitive function, larger
                      brain volumes, fewer SBIs, and less cognitive decline in the
                      community-based Framingham Heart Study.2,092 participants
                      (mean±SD, age 61±9) completed Food Frequency
                      Questionnaires, averaged across a maximum of 3-time points
                      (examination cycles 5, 6, and 7), cognitive testing at
                      examination cycle 7 (present study baseline: 1998-2001) and
                      after a mean±SD of 6.6±1.1 years from baseline (n =
                      1,584). A subset of participants also completed brain
                      magnetic resonance imaging (MRI) at examination cycle 7 (n =
                      1,904). In addition, participants with dementia, stroke, and
                      other relevant neurological diseases such as significant
                      head trauma, subdural hematoma, or multiple sclerosis were
                      excluded from the analyses.Higher MIND diet scores were
                      associated with better global cognitive function
                      (β±SE,+0.03SD±0.01; p = 0.004), verbal memory, visual
                      memory, processing speed, verbal comprehension/reasoning,
                      and with larger total brain volume (TBV) following
                      adjustments for clinical, lifestyle and demographic
                      covariates, but not with other brain MRI measures (i.e.,
                      hippocampal volume, lateral ventricular volume, white matter
                      hyperintensity volume, and SBIs) or cognitive decline.Higher
                      MIND diet scores associated with better cognitive
                      performance and larger TBV at baseline, but not with
                      cognitive decline. Clinical trials are needed to ascertain
                      whether adopting the MIND diet affects trajectories of
                      cognitive decline.},
      keywords     = {Aged / Asymptomatic Diseases / Brain: diagnostic imaging /
                      Brain: pathology / Brain Infarction: diagnosis / Brain
                      Infarction: epidemiology / Cognition: physiology / Cognitive
                      Dysfunction: epidemiology / Cognitive Dysfunction:
                      prevention $\&$ control / Diet, Mediterranean: psychology /
                      Diet, Mediterranean: statistics $\&$ numerical data / Female
                      / Humans / Longitudinal Studies / Magnetic Resonance
                      Imaging: methods / Male / Middle Aged / Neuropsychological
                      Tests / Organ Size / Patient Compliance: psychology /
                      Patient Compliance: statistics $\&$ numerical data /
                      Treatment Outcome / Apolipoprotein ɛ4 (Other) / MIND diet
                      (Other) / brain volume (Other) / cognition (Other) / dietary
                      pattern (Other) / framingham heart study (Other) / silent
                      brain infarcts (Other)},
      cin          = {AG Wagner / AG Klockgether},
      ddc          = {610},
      cid          = {I:(DE-2719)1011201 / I:(DE-2719)1011001},
      pnm          = {353 - Clinical and Health Care Research (POF4-353)},
      pid          = {G:(DE-HGF)POF4-353},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:34092629},
      doi          = {10.3233/JAD-201238},
      url          = {https://pub.dzne.de/record/162628},
}